Role of Antimiasmatic medicine in cases of chronic insomnia in age group 30 to 50 years assessed by Regensburg insomnia scale
试验速览
- 阶段
- 2/3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Insomnia will assessed with Regensburg Insomnia Scale
研究概览
简要总结
THIS STUDY IS PROSPECTIVE STUDY PRE TEST POST TEST ONE GROUP EXPERIMENTAL STUDY TO ASSESS THE ROLE OF ANTIMIASMATIC HOMOEOPATHIC MEDICINES FOR 6 MONTHS IN 40 PARTICIPANTS WITH CHRONIC INSOMNIA THAT WILL BE CONDUCTED AS PER INCLUSION AND EXCLUSION CRITERIA FROM OUT PATIENT DEPARTMENT AND THE PRIMARY OUTCOME MEASURE WILL ASSESS THE REDUCTION OF SEVERITY OF SCORE OF CHRONIC INSOMNIA OF PARTICIPANTS USING REGENSBURG INSOMNIA SCALE SCORE AT BASELINE AND EVERY 1 MONTH UPTO END OF TREATMENT FOR 6 MONTHS FOLLOW UP AS PER NEED OF CASE FOR 6 MONTHS OF DURATION
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 30.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Complain of sleep disturbances up to 3 months to 1 year Patient having chronic insomnia only due to anxiety stress and depression RIS (Regensburg insomnia scale) score up to 15 to 30 Patient who give consent as able to fill Regensburg insomnia scale.
排除标准
- •Having any general pathological disease which causes insomnia like Cancer Parkinson disease and any other sleep disorder Having any major psychiatric illness like schizophrenia bipolar disorder ADHD Taking any other medications related to insomnia Taking tobacco cigarette smoking and alcohol For Female taking any hormonal pills pregnancy and menopausal symptoms.
结局指标
主要结局
Insomnia will assessed with Regensburg Insomnia Scale
时间窗: Regensburg Insomnia Scale will assessed at baseline and every month upto 6 months
次要结局
未报告次要终点
研究者
DR BHARATKUMAR BHIKHABHAI PATEL
Smt A J Savla Homoeopathic Medical College and Research Institute